ELUT Elutia Inc.
0.8201USD+5.56%Mkt Cap: 36.32M $P/E: —1d ago
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiov…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap36.32M USD
Enterprise Value18.89M USD
Revenue (TTM)12.14M USD
Gross Profit6.60M USD
Net Income (TTM)53.38M USD
Revenue/Share0.28 USD
Last Price0.8201 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees25
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.71
PEG—
EV/EBITDA-0.89
EV/Revenue1.56
P/S2.84
P/B2.18
EPS (TTM)-0.64
EPS (Forward)-1.10
52W Range
0.500036% of range1.385
52W High1.385 USD
52W Low0.5000 USD
Profitability
Gross Margin53.66%
Oper. Margin-243.10%
EBITDA Margin-175.95%
Profit Margin434.23%
ROE192.90%
ROA85.61%
Growth
Revenue Growth-11.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-44.81M USD
CapEx (TTM)1.88M USD
FCF Margin-226.38%
FCF Yield-75.64%
Net Debt-15.52M USD
Net Debt/EBITDA0.73
Balance Sheet
Debt/Equity0.14
Current Ratio1.77
Quick Ratio1.01
Book Value/Sh0.36 USD
Cash/Share0.45 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.000 USD
Upside (mean)+509.7%
Target Range5.000 USD – 5.000 USD
# Analysts1
Ownership
Shares Out.44.29M
Float29.48M
Insiders3.58%
Institutions43.82%
Short Interest
Short Ratio0.2d
Short % Float0.02%
Short % Out.0.02%
Shares Short8.22K
Short (prev mo.)25.86K
Technical
SMA 500.8604 (-4.7%)
SMA 2000.9573 (-14.3%)
Beta0.84
S&P 52W Chg16.45%
Avg Vol (30d)95.42K
Avg Vol (10d)778.44K
Technical Indicators
RSI (14)48.7
MACD-0.0192
MACD Signal-0.0211
MACD Hist.+0.0019
BB Upper0.8621 USD
BB Middle0.8122 USD
BB Lower0.7622 USD
BB Width12.30%
ATR (14)0.0677 USD
Vol Ratio (20d)2.30x